Answers are grounded in this paper and cite their sources.
Coronavirus infectious disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused significant global morbidity and mortality since first emerging as a pathogen at the end of 2019. Acute kidney injury, most commonly due to acute tubular injury, is a frequent finding in COVID-19, occurring in 17% to 37% of patients.1–3 De novo glomerular disease is much less common with COVID-19, although cases of new-onset collapsing glomerulopathy, immune-complex glomerulonephritis, and antineutrophil cytoplasmic autoantibody (ANCA)–associated glomerulonephritis have been reported.
No takes yet. Share an insight, caveat, or question.
Dube et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: